Delivery Order SPE2DB20D3101-SPE2DB25FRNE1
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Zonisade 100 mg/5 ml oral suspension in a 150 ml quantity, with a ceiling value of $6,846.22. This non-competitive delivery order represents a firm fixed price transaction with an ultimate completion date of August 8, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The award was issued without a set-aside designation, indicating it...
- This federal contract award, valued at $11,573.30, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to deliver the medication Zonisade 100 mg/5 ml oral suspension in 150 ml bottles. This award is a delivery order under an Indefinite Delivery Contract (IDC) valued up to $999,999,999 with the DLA Troop Support Medical, which provides a wide range of medical commodities to support military treatment programs and facilities...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of ZONISADE 100 MG/5 ML ORAL SUSP 150ML, a pharmaceutical product, with a ceiling value of $1,122.49 and a period of performance through March 28, 2025. The contract is a firm fixed-price delivery order, and there is no set-aside designation indicated. AmerisourceBergen holds...
- This delivery order from the Defense Logistics Agency awards Amerisourcebergen Drug Corp $1,487.31 to supply 150ml of the oral suspension Zonisade 100 mg/5 ml. As the parent company, Amerisourcebergen Corporation will perform under the contract through its Corporate Office location in Conshohocken, Pennsylvania. The firm fixed price contract has an anticipated completion date of October 18, 2023 and did not utilize any set aside designations in the award. The Defense Logistics Agency supports...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,930.33, is for the delivery of ZONISADE 100 MG/5 ML ORAL SUSP 150ML, a pharmaceutical product. The contract does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
- This federal contract award is for the delivery of the pharmaceutical product "ZONISADE 100 MG/5 ML ORAL SUSP 150ML" to the Defense Logistics Agency (DLA), a defense agency within the U.S. Department of Defense. The contract, valued at $2,209.66, was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company that provides a wide range of medications and medical supplies to various federal agencies, particularly the Department of Defense and the Department of...
- This federal contract award, with an ID of SPE2DB22D3011|SPE2DB24FQ0NN, was granted to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $1,111.35 firm fixed price delivery order is for the supply of the medication Zonisade 100 mg/5 ml oral suspension in 150 ml bottles. The contract, which has an ultimate completion date of April 12, 2024, was awarded on April 11, 2024 by the Defense Logistics Agency (DLA), a defense...
- The Defense Logistics Agency awarded a $672 delivery order to Amerisourcebergen Drug Corporation for 4562180755 ZONISADE 100 MG/5 ML ORAL SUSP 150ML. The firm fixed price order is being fulfilled under an existing prime vendor contract vehicle and calls for the delivery of pharmaceutical products to a Defense Logistics Agency location in Conshohocken, Pennsylvania. Performance will take place from September 14 to 15, 2023. No subcontractors or set aside designations were identified. The...
- Defense Logistics Agency Troop Support Medical awarded a $1,223.64 firm fixed price delivery order to Amerisourcebergen Drug Corp for 100-count bottles of the 100mg Zonisamide capsule. Performance will occur in Conshohocken, Pennsylvania, with an expected completion date of October 12, 2023. The award was made on October 11, 2023 without a set-aside designation. As the parent company, Amerisourcebergen Corporation will support fulfillment through its Amerisourcebergen distribution division. This...
- This federal contract award, valued at $1,322.94, was issued by the Defense Logistics Agency (DLA) to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,566,790,175 units of the drug Zonisamide 100 mg capsules. The contract has an ultimate completion date of December 24, 2024 and is a Firm Fixed Price Delivery Order. There was no set-aside designation for this award. Amerisourcebergen Drug...
- SPE2DB20D3101Indefinite Delivery Contract
- SPE2DB20D3101-SPE2DB25FRNE1Delivery Order
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $1,839.68 for Zonisade 100 mg/5 ml oral suspension (150 ml) on June 17, 2025, with completion scheduled for June 18, 2025. This non-competitive, firm fixed-price delivery order was issued under a child contract structure and performed at the contractor's facility in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical procurement vendor, fulfills this order as part of its extensive portfolio of pharmaceutical supply contracts with the Defense Logistics Agency. This delivery order operates under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The IDC serves as a comprehensive global pharmaceutical support vehicle enabling the contractor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, including critical medical commodities such as specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. The contract supports customer organizations including the Defense Health Agency and U.S. Coast Guard through a flexible procurement mechanism aligned with DLA's medical supply chain requirements.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.8k | 6/17/25 |